These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16672188)

  • 21. Progress toward poliomyelitis eradication--Pakistan and Afghanistan, January 2005-May 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Jun; 55(24):679-82. PubMed ID: 16791135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress toward interruption of wild poliovirus transmission--worldwide, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(12):308-12. PubMed ID: 19343011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of genetic factors in polio eradication: new challenge for policy makers.
    Paul Y
    Vaccine; 2007 Dec; 25(50):8365-71. PubMed ID: 17996995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress toward interruption of wild poliovirus transmission--worldwide, January 2006-May 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Jul; 56(27):682-5. PubMed ID: 17625496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress toward poliomyelitis eradication--India, January 2005-June 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Jul; 55(28):772-6. PubMed ID: 16855526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
    Chowdhary R; Dhole TN
    J Med Virol; 2008 Aug; 80(8):1477-88. PubMed ID: 18551602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interrupting poliovirus transmission -- new solutions to an old problem.
    Aylward RB; Maher C
    Biologicals; 2006 Jun; 34(2):133-9. PubMed ID: 16682220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of iodized oil on trivalent oral polio vaccine in vitro.
    Bruning JH; van Nimwegen FW; Oostvogel P; van Steenis G; Cohen N
    Int J Vitam Nutr Res; 1994; 64(2):125-9. PubMed ID: 7960491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case for developing antiviral drugs against polio.
    Collett MS; Neyts J; Modlin JF
    Antiviral Res; 2008 Sep; 79(3):179-87. PubMed ID: 18513807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
    Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
    Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV?
    Khan MM
    Vaccine; 2008 Apr; 26(16):2034-40. PubMed ID: 18339460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk management in a polio-free world.
    Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D
    Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on vaccine-derived polioviruses.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Oct; 55(40):1093-7. PubMed ID: 17035927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigations of clinical isolations of oral poliovirus vaccine strains between 2000 and 2005 in southern Taiwan.
    Chi CY; Tseng FC; Liu DP; Chang YW; Wu HC; Huang YF; Hwang KP; Hsu YW; Wang SM; Liu CC; Wu HS; Yang JY; Yang CF; Wang JR; Su IJ
    J Clin Virol; 2009 Jun; 45(2):129-34. PubMed ID: 19394265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diarrhea as a minor adverse effect due to oral polio vaccine.
    Sugawara T; Ohsuka Y; Taya K; Yasui Y; Wada N; Sakano M; Koshida R; Fujii F; Shibata S; Hashimoto G; Utsumi H; Sumitomo M; Ishihara M; Kondo H; Sato H; Ueno K; Araki K; Okabe N
    Jpn J Infect Dis; 2009 Jan; 62(1):51-3. PubMed ID: 19168959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poisson-model analysis of the risk of vaccine-associated paralytic poliomyelitis in Japan between 1971 and 2000.
    Hao L; Toyokawa S; Kobayashi Y
    Jpn J Infect Dis; 2008 Mar; 61(2):100-3. PubMed ID: 18362395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Awareness about vaccine vial monitor at pulse polio booths.
    Chudasama RK
    Indian Pediatr; 2007 Dec; 44(12):919-20. PubMed ID: 18175846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants.
    Asturias EJ; Dueger EL; Omer SB; Melville A; Nates SV; Laassri M; Chumakov K; Halsey NA
    J Infect Dis; 2007 Sep; 196(5):692-8. PubMed ID: 17674310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dengue fever: from disease to vaccination].
    Teyssou R
    Med Trop (Mars); 2009 Aug; 69(4):333-4. PubMed ID: 19725380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Poliomyelitis--why we must continue to vaccinate!].
    Windorfer A; Beyrer K
    MMW Fortschr Med; 2005 Feb; 147(8):36, 38, 40. PubMed ID: 18437859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.